Antares Vision — Capital/Financing Update 2024

Apr 2, 2024

PRESS RELEASE

ANTARES VISION WARRANTS EXERCISE MODE AND RATIO – LAST EXERCISE PERIOD

Travagliato (Brescia), 2 April 2024 – Antares Vision S.p.A. ("Antares Vision" or the "Company") announces that, pursuant to article 3 of the Regulation of "Antares Vision S.p.A. Warrants" (respectively, the "Warrants Regulation" ¹ and the "Warrants"), the Average Monthly Price for March 2024 is Euro 2.5976 (source FactSet, Average Monthly Price calculated as the arithmetic average of the official prices of ordinary Antares Vision S.p.A. shares on stock market trading days in March).

Therefore, since the Average Monthly Price for March 2024, equal to Euro 2.5976, is lower than the Strike Price, equal to 9.50 euros, the warrants cannot be exercised during the month of April 2024.

The Company reminds that, pursuant to Article 5 of the Rules, Warrants not exercised on or before 19 April 2024 included ("Forfeiture Deadline") will forfeit all rights, becoming invalid for all purposes.

Antares Vision also announces that, in March, the warrants could not be exercised. Consequently, as a result of the capital increase reserved for the share incentive plan of the new CEO, Gianluca Mazzantini, the share capital of Antares Vision is now Euro 172,788.42 (divided into no. 71,943,149 ordinary shares, no. 250,000 Special Shares and no. 1,189,590 Performance Shares, all with no indication of par value). The number of Warrants still outstanding is 2,460,400.

For any further information, please refer to the Warrants Regulation available on the website of Antares Vision www.antaresvisiongroup.com - "Investors – Investor Relations – Warrant" section.

¹ The terms indicated in this press release with a capital letter have the same meaning as those contained in the Warrants Regulation.

PRESS RELEASE

ABOUT ANTARES VISION GROUP

Antares Vision Group is an outstanding technology partner in digitalization and innovation for companies and institutions, guaranteeing the safety of products and people, business competitiveness, and environmental protection. The Group provides a unique and comprehensive ecosystem of technologies to guarantee product quality (inspection systems and equipment) and end-to-end product traceability (from raw materials to production, from distribution to the consumer) through integrated data management, applying artificial intelligence and blockchain technology. Antares Vision Group is active in life science (pharmaceutical, biomedical devices and hospitals) and Fast-Moving Consumer Goods (FMCG), including food, beverage, cosmetics, and glass and metal containers. As a world leader in track and trace solutions for pharmaceutical products, the Group provides major global manufacturers (over 50% of the top 20 multinationals) and numerous government authorities with solutions, monitoring their supply chains and validating product authenticity. Listed since April 2019 on the Italian Stock Exchange in the Alternative Investment Market (AIM) segment and from 14 May 2021 in the STAR segment of Euronext; furthermore, from July 2022 included in the Euronext Tech Leaders index, dedicated to leading tech companies with high growth potential. In 2021, Antares Vision Group recorded a turnover of €179m, operates in 60 countries, employs more than 1,000 people, and has a consolidated network of over 40 international partners. To learn more, please visit www.antaresvisiongroup.com.

For further information

ISSUER

ANTARES VISION GROUP

ALESSANDRO BAJ BADINO (HEAD OF INVESTOR RELATIONS) TEL.: +39 030 72 83 500 E-MAIL: INVESTORS@ANTARESVISION.COM

DAVIDE ANTONIOLI (INVESTOR RELATOR) TEL.: +39 030 72 83 500 E-MAIL: INVESTORS@ANTARESVISION.COM